Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

ImmuCell Q1 EPS $(0.30) Down From $0.07 YoY, Sales $3.45M Down From $6.00M YoY

Author: Benzinga Newsdesk | May 11, 2023 04:37pm

ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.30) per share. This is a 528.57 percent decrease over earnings of $0.07 per share from the same period last year. The company reported $3.45 million in sales this quarter. This is a 42.55 percent decrease over sales of $6.00 million the same period last year.

Posted In: ICCC